Search Results

There are 17928 results for: content related to: The effects of methadone and its role in fatalities

  1. Methadone

    Medical Toxicology of Drug Abuse: Synthesized Chemicals and Psychoactive Plants

    Donald G. Barceloux, Pages: 579–602, 2012

    Published Online : 2 FEB 2012, DOI: 10.1002/9781118105955.ch32

  2. You have free access to this content
    Methadone increases intracellular calcium in SH-SY5Y and SH-EP1-hα7 cells by activating neuronal nicotinic acetylcholine receptors

    Journal of Neurochemistry

    Volume 94, Issue 5, September 2005, Pages: 1329–1341, Jukka S. Pakkanen, Heli Nousiainen, Jari Yli-Kauhaluoma, Irene Kylänlahti, Tommi Möykkynen, Esa R. Korpi, Jian-Hong Peng, Ronald J. Lukas, Liisa Ahtee and Raimo K. Tuominen

    Version of Record online : 5 JUL 2005, DOI: 10.1111/j.1471-4159.2005.03279.x

  3. You have free access to this content
    Steady-state pharmacokinetics of (R)- and (S)-methadone in methadone maintenance patients

    British Journal of Clinical Pharmacology

    Volume 50, Issue 5, November 2000, Pages: 427–440, David J. R. Foster, l Andrew A. Somogyi, 1,3 Kyle R. Dyer, 1,2 Jason M. White and 1 Felix Bochner 1,3

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2125.2000.00272.x

  4. Mechanism of Ritonavir Changes in Methadone Pharmacokinetics and Pharmacodynamics: I. Evidence Against CYP3A Mediation of Methadone Clearance

    Clinical Pharmacology & Therapeutics

    Volume 84, Issue 4, October 2008, Pages: 497–505, ED Kharasch, PS Bedynek, S Park, D Whittington, A Walker and C Hoffer

    Version of Record online : 9 JUL 2008, DOI: 10.1038/clpt.2008.104

  5. Mechanism of Efavirenz Influence on Methadone Pharmacokinetics and Pharmacodynamics

    Clinical Pharmacology & Therapeutics

    Volume 91, Issue 4, April 2012, Pages: 673–684, E D Kharasch, D Whittington, D Ensign, C Hoffer, P S Bedynek, S Campbell, K Stubbert, A Crafford, A London and T Kim

    Version of Record online : 7 MAR 2012, DOI: 10.1038/clpt.2011.276

  6. Pharmacokinetics and Pharmacodynamics of Methadone Enantiomers After Coadministration with Fosamprenavir-Ritonavir in Opioid-Dependent Subjects

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 28, Issue 7, July 2008, Pages: 863–874, Dr. Ying-Jun Cao, Dr. Patrick F. Smith, Dr. Mary Beth Wire, Ms. Yu Lou, Mr. Charles T. Lancaster, Dr. Roger C. Causon, Dr. George E. Bigelow, Dr. Elizabeth Martinez, Mr. Edward J. Fuchs, Dr. Christine Radebaugh, Dr. Sarah McCabe and Craig W. Hendrix

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.28.7.863

  7. The Effects of Once-Daily Saquinavir/Minidose Ritonavir on the Pharmacokinetics of Methadone

    The Journal of Clinical Pharmacology

    Volume 44, Issue 3, March 2004, Pages: 293–304, Dr Mark J. Shelton, Ms Denise Cloen, Ms Robin DiFrancesco, Dr Charles S. Berenson, Dr Andrew Esch, Dr Pascal J. de Caprariis, Ms Branka Palic, Ms Jane L. Schur, Mr Christopher J. L. Buggé, Mr Anders Ljungqvist, Mr Orlando Espinosa and Dr Ross G. Hewitt

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270003262956

  8. Buprenorphine-Based Regimens and Methadone for the Medical Management of Opioid Dependence: Selecting the Appropriate Drug for Treatment

    The American Journal on Addictions

    Volume 19, Issue 6, November-December 2010, Pages: 557–568, Icro Maremmani and Gilberto Gerra

    Version of Record online : 21 SEP 2010, DOI: 10.1111/j.1521-0391.2010.00086.x

  9. You have free access to this content
    Post-marketing Surveillance of Methadone and Buprenorphine in the United States

    Pain Medicine

    Volume 11, Issue 7, July 2010, Pages: 1078–1091, Nabarun Dasgupta, Elise J. Bailey, Theodore Cicero, James Inciardi, Mark Parrino, Andrew Rosenblum and Richard C. Dart

    Version of Record online : 8 JUN 2010, DOI: 10.1111/j.1526-4637.2010.00877.x

  10. Pharmacokinetics and Pharmacodynamics of Methadone Enantiomers After Coadministration with Amprenavir in Opioid-Dependent Subjects

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 24, Issue 9, September 2004, Pages: 1110–1121, Dr. Craig W. Hendrix, Dr. John Wakeford, Dr. Mary Beth Wire, Ms. Yu Lou, Dr. George E. Bigelow, Ms. Elizabeth Martinez, Mr. Jared Christopher, Mr. Edward J. Fuchs and Dr. Jerry W. Snidow

    Version of Record online : 16 JAN 2012, DOI: 10.1592/phco.24.13.1110.38091

  11. Population-based pharmacokinetic approach for methadone monitoring of opiate addicts: potential clinical utility


    Volume 95, Issue 12, December 2000, Pages: 1771–1783, K. Wolff, A. Rostami-Hodjegan, A. W. M. Hay, D. Raistrick and G. Tucker

    Version of Record online : 3 MAY 2002, DOI: 10.1046/j.1360-0443.2000.951217717.x

  12. Pharmacokinetic and Pharmacodynamic Study of the Concomitant Administration of Methadone and TMC125 in HIV-Negative Volunteers

    The Journal of Clinical Pharmacology

    Volume 48, Issue 3, March 2008, Pages: 322–329, Dr Monika Schöller-Gyüre, Dr Wim van den Brink, Dr Thomas N. Kakuda, Dr Brian Woodfall, Dr Goedel D. Smedt, Dr Hilde Vanaken, Ms Tanja Stevens, Ms Monika Peeters, Ms Kati Vandermeulen and Dr Richard M. W. Hoetelmans

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270007310387

  13. Gender-Specific Differences in Susceptibility to Low-Dose Methadone-Associated QTc Prolongation in Patients with Heroin Dependence

    Journal of Cardiovascular Electrophysiology


    Version of Record online : 2 DEC 2011, DOI: 10.1111/j.1540-8167.2011.02231.x

  14. Clinical eftects and pharmacokinetics of racemic methadone and its optical isomers

    Clinical Pharmacology & Therapeutics

    Volume 21, Issue 2, February 1977, Pages: 147–157, George D. Olsen, Herbert A. Wendel, James O. Livermore, Regina M. Leger, Robert K. Lynn and Nicholas Gerber

    Version of Record online : 4 JAN 2016, DOI: 10.1002/cpt1977212147

  15. Development of a method to measure methadone enantiomers and its metabolites without enantiomer standard compounds for the plasma of methadone maintenance patients

    Biomedical Chromatography

    Volume 24, Issue 7, July 2010, Pages: 782–788, Sheng-Chang Wang, Ing-Kang Ho, Shiow-Ling Wu, Shu Chih Liu, Hsiang-Wei Kuo, Keh-Ming Lin and Yu-Li Liu

    Version of Record online : 10 NOV 2009, DOI: 10.1002/bmc.1363

  16. Fatal methadone toxicity: signs and circumstances, and the role of benzodiazepines

    Australian and New Zealand Journal of Public Health

    Volume 26, Issue 4, August 2002, Pages: 358–362, John R.M. Caplehorn and Olaf H. Drummer

    Version of Record online : 25 SEP 2007, DOI: 10.1111/j.1467-842X.2002.tb00185.x

  17. Chloramphenicol significantly affects the pharmacokinetics of oral methadone in Greyhound dogs

    Veterinary Anaesthesia and Analgesia

    Volume 42, Issue 6, November 2015, Pages: 597–607, Butch KuKanich and Kate KuKanich

    Version of Record online : 2 MAR 2015, DOI: 10.1111/vaa.12257

  18. Pharmacokinetic interaction of nelfinavir and methadone in intravenous drug users

    Biopharmaceutics & Drug Disposition

    Volume 27, Issue 2, March 2006, Pages: 61–68, Poe-Hirr Hsyu, Jim Lillibridge, Elaine Daniels and Bradley M. Kerr

    Version of Record online : 21 NOV 2005, DOI: 10.1002/bdd.482

  19. You have free access to this content
    Pharmacological maintenance treatments of opiate addiction

    British Journal of Clinical Pharmacology

    Volume 77, Issue 2, February 2014, Pages: 253–263, James Bell

    Version of Record online : 22 JAN 2014, DOI: 10.1111/bcp.12051

  20. Stereoselective metabolism of methadone N-demethylation by cytochrome P4502B6 and 2C19


    Volume 16, Issue 1, 2004, Pages: 36–44, John G. Gerber, Robert J. Rhodes and Joseph Gal

    Version of Record online : 11 NOV 2003, DOI: 10.1002/chir.10303